5 drug(s) with this reaction
159 total reports
Hypoaesthesia Oral has been reported as an adverse reaction across 5 drug(s) manufactured by Haleon Us Holdings Llc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 159 adverse event reports mention hypoaesthesia oral in connection with Haleon Us Holdings Llc products.
This page provides a breakdown of which Haleon Us Holdings Llc drugs are most commonly associated with hypoaesthesia oral, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Haleon Us Holdings Llc drugs have hypoaesthesia oral listed in their FDA adverse event reports, sorted by report count:
In addition to hypoaesthesia oral, the following adverse reactions have been reported across Haleon Us Holdings Llc's drug portfolio:
5 drug(s) manufactured by Haleon Us Holdings Llc have hypoaesthesia oral listed in their FDA adverse event reports: DOCOSANOL, GLYCERIN, LIDOCAINE, STANNOUS FLUORIDE, POTASSIUM NITRATE, SODIUM FLUORIDE, POTASSIUM NITRATE AND SODIUM FLUORIDE.
There are a combined 159 reports of hypoaesthesia oral across 5 Haleon Us Holdings Llc drug(s) in the FDA adverse event database.